Company profile

Aignostics company profile

Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of precise heatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00101-00250 employees
Revenue range
$1K+
Founded
2018-01-01

Headquarters

Headquarters
Brackenheim, Baden-Wurttemberg, Germany
Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
5
Total equity funding
$54.8M
Last funding
Series B / $34M / 2024-10-29
Last equity funding
Series B / $34M
Investors
9
Lead investors
3
Founders
4
Articles
33

Founders and investors

Founders

Frederick KlauschenKlaus-Robert MüllerMaximilian AlberViktor Matyas

Lead investors

ATHOSBoehringer Ingelheim Venture FundWellington Partners

Investors

Boehringer Ingelheim Venture FundHTGF (High-Tech Gruenderfonds)IBB VenturesMayo ClinicWellington Partners

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.